Search | TVST | ARVO Journals

Showing 1 – 20 of 87

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Forecasting glaucoma from multimodal data using deep learning models

Xiaoqin Huang; Asma Poursoroush; Yeganeh Madadi; Hina Raja; Mohammad Delsoz; Louis R. Pasquale; Michael V. Boland; Chris A Johnson; Nazlee Zebardast; Siamak Yousefi

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):374.

ARVO Annual Meeting Abstract June 2023

Validation of a Novel Head-Mounted Perimeter versus the Humphrey Field Analyzer

Wisam Najdawi; Chris A Johnson; Andrew Pouw

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5496.

ARVO Annual Meeting Abstract June 2023

Predicting Visual Field Worsening with Longitudinal Optical Coherence Tomography Data Using a Gated Transformer Network

Kaihua Hou; Chris Bradley; Patrick Herbert; Chris A Johnson; Michael Wall; Pradeep Y Ramulu; Mathias Unberath; Jithin Yohannan

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):978.

ARVO Annual Meeting Abstract June 2023

Glaucoma subtyping based on visual field progression using unsupervised machine learning

Xiaoqin Huang; Asma Poursoroush; Jian Sun; Louis R Pasquale; Michael Boland; Chris A Johnson; Siamak Yousefi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):368.

ARVO Annual Meeting Abstract June 2023

Prediction model of visual field progression in the Ocular Hypertension Treatment Study

Mae O Gordon; Dale K Heuer; Eve J Higginbotham; Richard K Parrish; Chris A Johnson; Lei Liu; Michael A Kass

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):104.

ARVO Annual Meeting Abstract June 2022

An objective and easy-to-use glaucoma severity classification system based on artificial intelligence

Xiaoqin Huang; Fatemeh Saki; Mengyu Wang; Tobias Elze; Michael Boland; Louis Pasquale; Chris A Johnson; Siamak Yousefi

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2292.

ARVO Annual Meeting Abstract June 2022

A Comparison of Clinician and Deep Learning Performance at Detecting Visual Field Worsening

Kaihua Hou; Jasdeep Sabharwal; Patrick Herbert; Chris Bradley; Chris A Johnson; Michael Wall; Pradeep Y Ramulu; Mathias Unberath; Jithin Yohannan

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2014 – A0455.

ARVO Annual Meeting Abstract June 2022

Pre- and Post-POAG Rate of Visual Field Progression in the Ocular Hypertension Treatment (OHTS) Study

Mae e Gordon; James David Brandt; Dale K Heuer; Eve J higginbotham; Richard K Parrish II; Chris A Johnson; John L Keltner; Julia Huecker; Michael A Kass

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3495.

ARVO Annual Meeting Abstract June 2022

Incidence and risk factors for recurrent visual field progression in glaucoma

Alessandro A Jammal; Tais Estrela; Chris A Johnson; Michael Wall; Felipe Medeiros

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1282 – A0422.

ARVO Annual Meeting Abstract June 2022

Convolutional Neural Network for Glaucoma detection using Compass color fundus images

CHIARA RUI; Silvia Gazzina; Giovanni Montesano; David P. Crabb; David F Garway-Heath; Francesco Oddone; Paolo Lanzetta; Paolo Brusini; Chris A Johnson; Paolo Fogagnolo; Luca M Rossetti

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2039 – A0480.

ARVO Annual Meeting Abstract June 2022

Staging Structural Damage in Glaucoma Based on Optical Coherence Tomography

Siamak Yousefi; Xiaoqin Huang; Paolo Brusini; Chris A Johnson

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2024 – A0465.

Articles October 2021

Demographic, Comorbid, and Clinical Variables Associated With Pointwise Visual Field Damage in Glaucoma: Data From the AGIS and CIGTS Clinical Trials

PDF

Brenda W. Gillespie; Leslie M. Niziol; Joshua R. Ehrlich; Chris A. Johnson; Joseph Caprioli; Paul C. VanVeldhuisen; Paul R. Lichter; David C. Musch
TAGS: comorbidity, demography, glaucoma, visual fields, hypertension, eye, diabetes mellitus, diabetes mellitus, type 2
Trans. Vis. Sci. Tech.. 2021; 10(12):28. https://doi.org/10.1167/tvst.10.12.28

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Do additional testing locations improve the detection of macular perimetric defects in glaucoma?

Giovanni Montesano; Allison M McKendrick; Andrew Turpin; Paolo Brusini; Francesco Oddone; Paolo Fogagnolo; Andrea Perdicchi; Chris A Johnson; Paolo Lanzetta; Luca Mario Rossetti; David F Garway-Heath; David P. Crabb

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3485.

ARVO Annual Meeting Abstract June 2021

Detecting Glaucoma Progression using Deep Archetypal Analysis of Retinal Nerve Fiber Layer Thickness Measurements

Sidharth Mahotra; Xiaoqin Huang; Tobias Elze; Mengyu Wang; Michael V Boland; Louis Pasquale; Juleke Eugenie Anne Majoor; Koenraad Arndt Vermeer; Hans Lemij; Kouros Nouri-Mahdavi; Chris A Johnson; Siamak Yousefi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3357.

ARVO Annual Meeting Abstract June 2021

Detection of Glaucoma Progression from Retinal Nerve Fiber Layer Thickness Measurements Using Machine Learning

Xiaoqin Huang; Sidharth Mahotra; Tobias Elze; Mengyu Wang; Michael V. Boland; Louis Pasquale; Juleke Eugenie Anne Majoor; Hans Lemij; Kouros Nouri-Mahdavi; Chris A Johnson; Siamak Yousefi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1005.

Articles March 2021

Effect of Initial Aflibercept, Laser, or Observation on Low-Contrast Visual Acuity in Eyes With Diabetic Macular Edema and Good Vision: Ancillary Study Within a Randomized Clinical Trial

PDF

Wesley T. Beaulieu; Adam R. Glassman; Carl W. Baker; Maureen G. Maguire; Chris A. Johnson; Michele Melia; Jennifer K. Sun; for the DRCR Retina Network
TAGS: aflibercept, clinical trials, diabetic macular edema, eye, lasers, vision, visual acuity
Trans. Vis. Sci. Tech.. 2021; 10(3):3. https://doi.org/10.1167/tvst.10.3.3

ARVO Annual Meeting Abstract July 2019

Effects of fundus tracking on structure-function relationship in glaucoma

Giovanni Montesano; Luca Mario Rossetti; Paolo Fogagnolo; Francesco Oddone; Paolo Lanzetta; Andrea Perdicchi; Chris A Johnson; David F Garway-Heath; David P Crabb

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3922.

ARVO Annual Meeting Abstract July 2019

Effect of additional testing locations on the evaluation of macular perimetric defects in glaucoma

Dario Romano; Giovanni Montesano; Paolo Fogagnolo; Allison M McKendrick; Andrew Turpin; Francesco Oddone; Paolo Lanzetta; Paolo Brusini; Andrea Perdicchi; Chris A Johnson; David F Garway-Heath; David P Crabb; Luca Mario Rossetti

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2458.

ARVO Annual Meeting Abstract July 2019

Test-retest variability in anatomically defined visual field clusters with fundus perimetry

Antonio Mattia Modarelli; Giovanni Montesano; Paolo Fogagnolo; Francesco Oddone; Paolo Lanzetta; Andrea Perdicchi; Chris A Johnson; David F Garway-Heath; David P Crabb; Luca Mario Rossetti

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2479.

Retina November 2018

Disorganization of Retinal Inner Layers (DRIL) and Neuroretinal Dysfunction in Early Diabetic Retinopathy

PDF

Katherine A. Joltikov; Christopher A. Sesi; Vinícius M. de Castro; José R. Davila; Rohit Anand; Sami M. Khan; Neil Farbman; Gregory R. Jackson; Chris A. Johnson; Thomas W. Gardner
TAGS: contrast sensitivity, diabetes mellitus, diabetic retinopathy, pathophysiology, spectral domain-optical coherence tomography, visual acuity, shedler-westen assessment procedure–200, fundus photography, perimetry
Invest. Ophthalmol. Vis. Sci.. 2018; 59(13):5481-5486. https://doi.org/10.1167/iovs.18-24955

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Forecasting glaucoma from multimodal data using deep learning models

Validation of a Novel Head-Mounted Perimeter versus the Humphrey Field Analyzer

Predicting Visual Field Worsening with Longitudinal Optical Coherence Tomography Data Using a Gated Transformer Network

Glaucoma subtyping based on visual field progression using unsupervised machine learning

Prediction model of visual field progression in the Ocular Hypertension Treatment Study

An objective and easy-to-use glaucoma severity classification system based on artificial intelligence

A Comparison of Clinician and Deep Learning Performance at Detecting Visual Field Worsening

Pre- and Post-POAG Rate of Visual Field Progression in the Ocular Hypertension Treatment (OHTS) Study

Incidence and risk factors for recurrent visual field progression in glaucoma

Convolutional Neural Network for Glaucoma detection using Compass color fundus images

Staging Structural Damage in Glaucoma Based on Optical Coherence Tomography

Demographic, Comorbid, and Clinical Variables Associated With Pointwise Visual Field Damage in Glaucoma: Data From the AGIS and CIGTS Clinical Trials

Do additional testing locations improve the detection of macular perimetric defects in glaucoma?

Detecting Glaucoma Progression using Deep Archetypal Analysis of Retinal Nerve Fiber Layer Thickness Measurements

Detection of Glaucoma Progression from Retinal Nerve Fiber Layer Thickness Measurements Using Machine Learning

Effect of Initial Aflibercept, Laser, or Observation on Low-Contrast Visual Acuity in Eyes With Diabetic Macular Edema and Good Vision: Ancillary Study Within a Randomized Clinical Trial

Effects of fundus tracking on structure-function relationship in glaucoma

Effect of additional testing locations on the evaluation of macular perimetric defects in glaucoma

Test-retest variability in anatomically defined visual field clusters with fundus perimetry

Disorganization of Retinal Inner Layers (DRIL) and Neuroretinal Dysfunction in Early Diabetic Retinopathy

To View More...

You must be signed into an individual account to use this feature.